272 related articles for article (PubMed ID: 11051308)
1. Promethazine as a motion sickness treatment: impact on human performance and mood states.
Cowings PS; Toscano WB; DeRoshia C; Miller NE
Aviat Space Environ Med; 2000 Oct; 71(10):1013-22. PubMed ID: 11051308
[TBL] [Abstract][Full Text] [Related]
2. Autogenic-feedback training exercise is superior to promethazine for control of motion sickness symptoms.
Cowings PS; Toscano WB
J Clin Pharmacol; 2000 Oct; 40(10):1154-65. PubMed ID: 11028255
[TBL] [Abstract][Full Text] [Related]
3. Motion-sickness medications for aircrew: impact on psychomotor performance.
Paul MA; MacLellan M; Gray G
Aviat Space Environ Med; 2005 Jun; 76(6):560-5. PubMed ID: 15945400
[TBL] [Abstract][Full Text] [Related]
4. Central effects of cinnarizine: restricted use in aircrew.
Nicholson AN; Stone BM; Turner C; Mills SL
Aviat Space Environ Med; 2002 Jun; 73(6):570-4. PubMed ID: 12056673
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antimotion sickness drug side effects on performance.
Wood CD; Manno JE; Manno BR; Redetzki HM; Wood MJ; Mims ME
Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
[TBL] [Abstract][Full Text] [Related]
6. Side effects of antimotion sickness drugs.
Wood CD; Manno JE; Manno BR; Redetzki HM; Wood M; Vekovius WA
Aviat Space Environ Med; 1984 Feb; 55(2):113-6. PubMed ID: 6696702
[TBL] [Abstract][Full Text] [Related]
7. Effects of some motion sickness suppressants on static and dynamic tracking performance.
Schroeder DJ; Collins WE; Elam GW
Aviat Space Environ Med; 1985 Apr; 56(4):344-50. PubMed ID: 3994616
[TBL] [Abstract][Full Text] [Related]
8. Chlorpheniramine for motion sickness.
Buckey JC; Alvarenga D; Cole B; Rigas JR
J Vestib Res; 2004; 14(1):53-61. PubMed ID: 15156097
[TBL] [Abstract][Full Text] [Related]
9. Comparison of treatment strategies for Space Motion Sickness.
Davis JR; Jennings RT; Beck BG
Microgravity Q; 1992 Jul; 2(3):173-7. PubMed ID: 11541442
[TBL] [Abstract][Full Text] [Related]
10. Airsickness prevention in helicopter passengers.
Estrada A; LeDuc PA; Curry IP; Phelps SE; Fuller DR
Aviat Space Environ Med; 2007 Apr; 78(4):408-13. PubMed ID: 17484344
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of antimotion sickness drugs.
Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
[TBL] [Abstract][Full Text] [Related]
12. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea-Air-Land.
Lieberman HR; Tharion WJ; Shukitt-Hale B; Speckman KL; Tulley R
Psychopharmacology (Berl); 2002 Nov; 164(3):250-61. PubMed ID: 12424548
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for nonsedating antihistamines in motion sickness? Fallout from space research may soon benefit your patients.
Kohl RL
J Respir Dis; 1991 Apr; 12(4 Suppl):S17-21. PubMed ID: 11542203
[TBL] [Abstract][Full Text] [Related]
14. Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness.
Muth ER; Jokerst M; Stern RM; Koch KL
Aviat Space Environ Med; 1995 Nov; 66(11):1041-5. PubMed ID: 8588792
[TBL] [Abstract][Full Text] [Related]
15. Effects of drug countermeasures for space motion sickness on working memory in humans.
Paule MG; Chelonis JJ; Blake DJ; Dornhoffer JL
Neurotoxicol Teratol; 2004; 26(6):825-37. PubMed ID: 15451046
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness.
Dornhoffer J; Chelonis JJ; Blake D
Otol Neurotol; 2004 Sep; 25(5):740-5. PubMed ID: 15354005
[TBL] [Abstract][Full Text] [Related]
17. The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness.
Levine ME; Chillas JC; Stern RM; Knox GW
Aviat Space Environ Med; 2000 Nov; 71(11):1111-4. PubMed ID: 11086664
[TBL] [Abstract][Full Text] [Related]
18. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
Graybiel A; Knepton J; Shaw J
Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
[TBL] [Abstract][Full Text] [Related]
19. A comparison of some effects of three antimotion sickness drugs on nystagmic responses to angular accelerations and to optokinetic stimuli.
Collins WE; Schroeder DJ; Elam GW
Aviat Space Environ Med; 1982 Dec; 53(12):1182-9. PubMed ID: 7159338
[TBL] [Abstract][Full Text] [Related]
20. High dose ondansetron for reducing motion sickness in highly susceptible subjects.
Muth ER; Elkins AN
Aviat Space Environ Med; 2007 Jul; 78(7):686-92. PubMed ID: 17679566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
